Invention Grant
- Patent Title: Pharmaceutical composition comprising polypeptide
-
Application No.: US15558893Application Date: 2016-03-16
-
Publication No.: US09987368B2Publication Date: 2018-06-05
- Inventor: Tatsuya Miyazaki , Kenji Masaki , Komei Okabe , Kazuhito Yamada
- Applicant: SANTEN PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Osaka-Shi, Osaka
- Assignee: SANTEN PHARMACEUTICAL CO., LTD.
- Current Assignee: SANTEN PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Osaka-Shi, Osaka
- Agency: Buchanan, Ingersoll & Rooney PC
- Priority: JP2015-053757 20150317
- International Application: PCT/JP2016/058359 WO 20160316
- International Announcement: WO2016/148201 WO 20160922
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K47/42 ; C07K7/08 ; A61K47/22 ; A61K47/20 ; A61K45/00 ; A61K47/10 ; A61K31/095 ; C08L71/08 ; C07C317/04 ; A61K31/444

Abstract:
Found out is a pharmaceutical composition that sustained-releases a drug for a long term after administration into the body. Provided is a pharmaceutical composition comprising a drug and a polypeptide represented by Ac-(Arg-Ala-Asp-Ala)4-NH2, and further containing an organic solvent selected from the group consisting of polyethylene glycol, dimethyl sulfoxide, glycofurol, and N-methylpyrrolidone.
Public/Granted literature
- US20180064818A1 PHARMACEUTICAL COMPOSITION COMPRISING POLYPEPTIDE Public/Granted day:2018-03-08
Information query
IPC分类: